Ginkgo Biloba: The World’s Most Studied Herbal Nootropic
Ginkgo Biloba is derived from one of the oldest tree species on Earth — a living fossil whose medicinal use dates back 5,000 years in Traditional Chinese Medicine. Today, it remains one of the most prescribed botanical medicines in Europe (particularly Germany and France) and one of the most researched supplements for cognitive function.
Active Compounds & Mechanisms
Standardized Ginkgo Biloba extract (EGb 761) contains two key compound classes:
- Flavonol glycosides (24%) — quercetin, kaempferol, isorhamnetin; potent antioxidants that protect neurons from oxidative damage
- Terpene lactones (6%) — ginkgolides A, B, C, and bilobalide; improve cerebral microcirculation and act as platelet activating factor (PAF) antagonists
Together, these compounds deliver three core mechanisms: cerebral blood flow enhancement, antioxidant neuroprotection, and anti-neuroinflammatory effects.
Clinical Evidence
1. Meta-Analysis of 21 RCTs (Tan et al., 2015)
The most comprehensive systematic review of Ginkgo Biloba for cognitive function analyzed 21 randomized controlled trials involving over 2,600 patients. Published in the Journal of Alzheimer’s Disease (PMID: 25589719), it confirmed significant improvements in cognitive function, daily activities, and neuropsychiatric symptoms in patients with dementia or cognitive impairment at 120–240 mg/day EGb 761.
2. Attention & Working Memory (Mix & Crews, 2002)
A double-blind RCT in healthy older adults found significant improvements in sustained attention, working memory, and processing speed after 6 weeks at 180 mg/day Ginkgo extract (PMID: 12230022).
3. Anxiety in Healthy Adults
A separate line of research confirms that Ginkgo’s PAF antagonist activity reduces stress-induced cortisol response, contributing to an anxiolytic effect observed in multiple trials.
Dosage Guide
| Target | Recommended Dose | Standardization |
|---|---|---|
| General cognitive support | 120 mg/day | 24% flavonol glycosides / 6% terpene lactones |
| Mild cognitive impairment / older adults | 240 mg/day | EGb 761 preferred |
| Acute attention boost (short-term) | 120–360 mg single dose | Standardized extract |
Important Safety Notes
- ⚠️ Drug interactions: Warfarin, aspirin, NSAIDs, SSRIs — increased bleeding risk
- ⚠️ Surgery: Discontinue 2 weeks before any surgical procedure
- ⚠️ Seizure history: May lower seizure threshold in rare cases
- ✅ Generally well-tolerated in healthy adults at standard doses
Evidence Summary
| Outcome | Evidence Level | Key Reference |
|---|---|---|
| Cognitive function (MCI/dementia) | Strong — meta-analysis of 21 RCTs | PMID: 25589719 |
| Attention & working memory | Moderate — multiple RCTs | PMID: 12230022 |
| Cerebral blood flow | Strong — documented mechanism | Multiple |
| Anxiety reduction | Moderate — clinical trial data | Multiple |
Ginkgo Biloba has one of the most extensive clinical evidence bases of any herbal supplement, particularly for older adults and those with mild cognitive impairment. Use only standardized EGb 761 extract at 120–240 mg/day. Key caution: check for drug interactions, especially with blood thinners.
Note: This page is for informational purposes only. Consult your doctor before supplementing, especially if you take medications.
